FindTrial
Sign In

Development and validation of a Nomogram model for individualized prediction of early gastric cancer risk before gastroscopy

Development and validation of a Nomogram model for individualized prediction of early gastric cancer risk before gastroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068657
Enrollment
Unknown
Registered
2023-02-27
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

observation group:None

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged 18-79 years who will visit the digestive endoscopy center of our hospital from August 1, 2022 to December 31, 2023 for gastroscopy; (2) Subjects voluntarily join the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with contraindications for gastroscopic tissue biopsy (such as those who are taking aspirin, warfarin, dabigatlan and other anticoagulants, or those with coagulation dysfunction); (2) Who cannot effectively complete the questionnaire survey.

Design outcomes

Primary

MeasureTime frame
Detection rate of early gastric cancer;receiver operating characteristic,ROC;calibration curve,CC;—

Countries

China

Contacts

Public ContactSun Da-Yong

Shenzhen Second People's Hospital

szsesdy@163.com+8613612908866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026